why choose us

First received: October 11, 2023

Clinical Trial: A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Rheumatoid Arthritis

Study Type: INTERVENTIONAL


Official Title: A Phase 1b, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Imvotamab in Participants With Moderate to Severe Rheumato

Brief Summary: The purpose of this study is to determine the safety and tolerability of imvotamab in patients with moderate to severe rheumatoid arthritis who have failed prior therapies.Participants will be given imvotamab or placebo through a vein (i.e., intravenously).A placebo is a look-alike substance that contains no active drug

Read more